Search Results

You are looking at 1 - 8 of 8 items for :

  • Endocrine Society of Australia special collection x
  • Refine by access: All content x
Clear All
Jun Yang Centre of Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria, Australia
Department of Medicine, Monash University, Clayton, Victoria, Australia

Search for other papers by Jun Yang in
Google Scholar
PubMed
Close
,
Morag J Young Cardiovascular Endocrinology Laboratory, Discovery & Preclinical Domain, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia

Search for other papers by Morag J Young in
Google Scholar
PubMed
Close
,
Timothy J Cole Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia

Search for other papers by Timothy J Cole in
Google Scholar
PubMed
Close
, and
Peter J Fuller Centre of Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria, Australia

Search for other papers by Peter J Fuller in
Google Scholar
PubMed
Close

, we explore the spectrum of clinical manifestations of PA and their molecular basis with a shift from the traditional focus on the MR as a regulator of renal sodium–potassium exchange to a broader understanding of its role in the modulation of tissue

Free access
Ken KY Ho Garvan Institute of Medical Research, St. Vincent’s Hospital and the UNSW Sydney, Sydney, New South Wales, Australia

Search for other papers by Ken KY Ho in
Google Scholar
PubMed
Close
,
Anthony J O’Sullivan St. George Hospital and the Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia

Search for other papers by Anthony J O’Sullivan in
Google Scholar
PubMed
Close
, and
Morton G Burt Southern Adelaide Diabetes and Endocrine, Flinders Medical Centre and College of Medicine and Public Health, and Flinders University, Adelaide, South Australia, Australia

Search for other papers by Morton G Burt in
Google Scholar
PubMed
Close

indicating that GH acts on organs, tissues, and body systems beyond effects on growth and metabolism ( Ballesteros et al. 2000 ). Table 1 shows the widespread actions on the tissues and organs of various systems including the renal, cardiovascular

Free access
Kirsty G Pringle School of Biomedical Sciences & Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, New South Wales, Australia
Mothers and Babies Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia

Search for other papers by Kirsty G Pringle in
Google Scholar
PubMed
Close
and
Lisa K Philp Australian Prostate Cancer Research Centre - Queensland, Centre for Genomics and Personalised Health & School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, Brisbane, Queensland, Australia

Search for other papers by Lisa K Philp in
Google Scholar
PubMed
Close

Introduction Angiotensin-converting enzyme 2 (ACE2) is a critical regulator of cardiovascular, respiratory, renal, and gastrointestinal physiology and pathology, through its actions as part of the renin–angiotensin system (RAS) and kallikrein

Free access
Emma J Hamilton Medical School, University of Western Australia, Fiona Stanley Hospital, Murdoch and Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Murdoch, Western Australia, Australia

Search for other papers by Emma J Hamilton in
Google Scholar
PubMed
Close
and
Stephen M Twigg Central Clinical School, Sydney Medical School, the Faculty of Medicine and Health, University of Sydney and Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia

Search for other papers by Stephen M Twigg in
Google Scholar
PubMed
Close

as heart failure and renal disease impairing wound healing whilst at the same time DFU-associated changes such as chronic inflammation promoting premature onset of cardiovascular, renal and musculoskeletal disease in this high-risk patient group

Free access
Renea A Taylor Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia
Department of Physiology, Biomedicine Discovery Institute, Cancer Program, Monash University, Melbourne, Victoria, Australia
Prostate Cancer Research Program, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Cabrini Institute, Cabrini Health, Malvern, Victoria, Australia

Search for other papers by Renea A Taylor in
Google Scholar
PubMed
Close
,
Mitchell G Lawrence Department of Physiology, Biomedicine Discovery Institute, Cancer Program, Monash University, Melbourne, Victoria, Australia
Prostate Cancer Research Program, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Cabrini Institute, Cabrini Health, Malvern, Victoria, Australia
Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Cancer Program, Monash University, Melbourne, Victoria, Australia

Search for other papers by Mitchell G Lawrence in
Google Scholar
PubMed
Close
, and
Gail P Risbridger Department of Physiology, Biomedicine Discovery Institute, Cancer Program, Monash University, Melbourne, Victoria, Australia
Prostate Cancer Research Program, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Cabrini Institute, Cabrini Health, Malvern, Victoria, Australia
Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Cancer Program, Monash University, Melbourne, Victoria, Australia

Search for other papers by Gail P Risbridger in
Google Scholar
PubMed
Close

microenvironment (sub-renal grafting), stromal stimuli, and hormone environment, extended time to establishment (average time to first graft for MURAL PDXs is ~220 days) ( Risbridger et al. 2021 ). Once established as serial transplantable grafts, PDXs can be

Free access
Gary A Wittert Freemasons Centre for Male Health and Wellbeing, South Australian Health and Medical Research Institute, and University of Adelaide, Adelaide, South Australia, Australia

Search for other papers by Gary A Wittert in
Google Scholar
PubMed
Close
,
Mathis Grossmann Department of Medicine, The University of Melbourne and Department of Endocrinology Austin Health, Heidelberg, Australia

Search for other papers by Mathis Grossmann in
Google Scholar
PubMed
Close
,
Bu B Yeap Medical School, University of Western Australia, and Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Perth, Western Australia, Australia

Search for other papers by Bu B Yeap in
Google Scholar
PubMed
Close
, and
David J Handelsman ANZAC Research Institute, University of Sydney and Andrology Department, Concord Hospital, Sydney, New South Wales, Australia

Search for other papers by David J Handelsman in
Google Scholar
PubMed
Close

), hepcidin and ferroportin ( Roth et al. 2019 ). The primary stimulus to renal production of the cytokine, EPO, is hypoxia ( Bachman et al. 2014 ). Hepcidin inhibits absorption of iron in the gut by binding to the iron transporter ferroportin and

Free access
Sunita M C De Sousa Endocrine & Metabolic Unit, Royal Adelaide Hospital, Adelaide, Australia
South Australian Adult Genetics Unit, Royal Adelaide Hospital, Adelaide, Australia
Adelaide Medical School, University of Adelaide, Adelaide, Australia

Search for other papers by Sunita M C De Sousa in
Google Scholar
PubMed
Close
,
Nèle F Lenders Department of Endocrinology, St Vincent’s Hospital, Sydney, NSW, Australia
Garvan Institute of Medical Research, Sydney, NSW, Australia
St Vincent’s Clinical School, University of New South Wales, Sydney, NSW, Australia

Search for other papers by Nèle F Lenders in
Google Scholar
PubMed
Close
,
Lydia S Lamb Garvan Institute of Medical Research, Sydney, NSW, Australia
St Vincent’s Clinical School, University of New South Wales, Sydney, NSW, Australia

Search for other papers by Lydia S Lamb in
Google Scholar
PubMed
Close
,
Warrick J Inder Department of Diabetes and Endocrinology, Princess Alexandra Hospital, Brisbane, Australia
Academy for Medical Education, Faculty of Medicine, the University of Queensland, Brisbane, Australia

Search for other papers by Warrick J Inder in
Google Scholar
PubMed
Close
, and
Ann McCormack Department of Endocrinology, St Vincent’s Hospital, Sydney, NSW, Australia
Garvan Institute of Medical Research, Sydney, NSW, Australia
St Vincent’s Clinical School, University of New South Wales, Sydney, NSW, Australia

Search for other papers by Ann McCormack in
Google Scholar
PubMed
Close

(HIF-1α) ( Xekouki et al. 2015 ). A deep intronic SDHC variant causing aberrant splicing has also been found in a large Australian kindred affected by all four SDHx -related tumours, namely: paraganglioma, PA, renal cell carcinoma and

Free access
Adam Hagg School of Biomedical Sciences, University of Queensland, Brisbane, Australia

Search for other papers by Adam Hagg in
Google Scholar
PubMed
Close
,
Eliza O’Shea School of Biomedical Sciences, University of Queensland, Brisbane, Australia

Search for other papers by Eliza O’Shea in
Google Scholar
PubMed
Close
,
Craig A Harrison Department of Physiology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia

Search for other papers by Craig A Harrison in
Google Scholar
PubMed
Close
, and
Kelly L Walton School of Biomedical Sciences, University of Queensland, Brisbane, Australia
Department of Physiology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia

Search for other papers by Kelly L Walton in
Google Scholar
PubMed
Close

experience symptoms with life-threatening potential including abdominal distension, vomiting and/or diarrhoea, respiratory complications, blood volume insufficiency and thickening, vascular thrombosis and renal failure ( Humaidan et al. 2016 ). A more

Free access